For the period of April to June, Novo Nordisk reported a net profit of 19.4 billion kroner ($2.9 billion), a 46-percent rise compared to a year earlier.
Net sales for the period reached 54.3 billion kroner, a rise of 32 percent, but falling short of analyst expectations of 55.1 to 55.5 billion, according to surveys by Bloomberg and FactSet.
Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details